Xulane 150-35 MCG/day patch 3S
Ended Awarded Last action
- Contract number
- SPE2DR26FWHY8
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $15,738
Award facts
- Contract value 100% obligated
- $15,737.78 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency (DLA) awarded a $15,737.78 delivery order to AmerisourceBergen Drug Corp for the supply of Xulane 150-35 mcg/day contraceptive patches (3-count units) on January 27, 2026, with completion expected by January 28, 2026. This firm fixed-price contract is non-set-aside and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The award represents a task order issued under AmerisourceBergen's parent company Cencora, Inc.'s larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, a comprehensive pharmaceutical supply vehicle valued at up to $999,999,999 through December 31, 2031, which supports military healthcare programs globally.
AmerisourceBergen Drug Corp serves as a critical pharmaceutical distributor for federal medical procurement, particularly supplying the Defense Health Agency and military treatment facilities. This delivery order is typical of the company's extensive portfolio of competitively awarded contracts with the DLA, which encompass prescription medications, generic drugs, vaccines, and specialized medical supplies across multiple therapeutic domains. The short completion timeline and modest order value reflect the flexibility inherent in the parent IDC structure, enabling the DLA to procure specific pharmaceutical products efficiently to support ongoing military healthcare operations.
Quick answers
Who was awarded contract SPE2DR26FWHY8?
SPE2DR26FWHY8 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 27, 2026.
How much is contract SPE2DR26FWHY8 worth?
The government has obligated $15,738 on SPE2DR26FWHY8.
Is contract SPE2DR26FWHY8 an order under another contract?
Yes. SPE2DR26FWHY8 is a delivery order under SPE2DR25D3009, an indefinite delivery contract.
Was contract SPE2DR26FWHY8 competed?
The extent of competition for SPE2DR26FWHY8 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award